The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Trends in endocrinology and metabolism

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1043-2760(00)00319-2PMID 11273567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Assessing the efficacy of spironolactone on adult acne in subjects with polycystic ovary syndrome

  2022cites this paper
• Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research

  2021cites this paper
• Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.

  2006cites this paper
• Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features, insulin sensitivity and lipid profile

  2005cites this paper
• Association of Insulin Resistance with Hyperandrogenia in Women

  2001cites this paper